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1. Introduction 
Diabetes mellitus is a group of metabolic diseases characterised by chronic hyperglycemia 
resulting from defects in insulin secretion and/or insulin action, or both [1].  The history of 
diabetes dates back to  1550 BC as the polyuric states were described in  an Egyptian 
papyrus, where  treatment was given with a four day decoction of bones, wheat, grain, grit 
and earth.  The term diabetes was coined by Aretaeus of Cappadocia in the 2nd century AD 
for conditions causing increased urine output.  The sweet taste of diabetic urine was noted 
in the 5th century AD by Indian physicians and in 1776, Matthew Dobson confirmed that 
diabetic serum and urine contained sugar.  The revolution in the history of Diabetes was the 
discovery of insulin by Banting, Best and colleagues in 1922 (http://wwunix.oit.umass.edu 
/~abhu000/diabetes/index.html). 
Type 1 diabetes mellitus (T1DM) is one of the most common endocrine metabolic disorders 
in children and adolescence worldwide with serious acute and chronic complications.  It has 
been proven that T1DM represents the ending result of an autoimmune destruction of the 
pancreatic islet beta cells in genetically susceptible individuals exposed to certain but still 
unclear environmental factors. The precise cause of T1DM is not known. However, multiple 
genetic and environmental risk factors seem to play an important role in the genesis of the 
disease. The genetic background is complex and difficult to be explained by the involvement 
of HLA gene region alone. On the other hand viral and nutritional factors changing 
continuously from country to country, may contribute to the etiology of T1DM. There is no 
doubt that monitoring temporal trends and incidence of T1DM contribute to the 
international effort to determine the exact pathogenesis of the disease and it is of critical 
public health importance. All these temporal trends in the incidence of T1DM have 
provided significant clues for understanding the disease, most likely reflecting 
environmental changes more than genetic changes and detecting the factors that implicated 
in this increase. 
In this chapter we review the changing trends in the epidemiology of T1DM and we present 
data on the rising incidence of T1DM in Greek Cypriot population. 
2. Incidence-changing trends  
The prevalence of T1DM greatly varies between different countries, within countries, and 
between different ethnic populations. The global variation of the incidence of T1DM is 
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evaluated by grouping the populations with very low (<1/100.000 per yr), low (1-4/100.000 
per yr), intermediate (5-9.99/100.000 per yr), high (10-19.99/100.000 per yr) and very high 
(>20/100.000 per yr) incidence [2]. The different annual incidence rates of T1DM comparing 
different countries of the world (0.1 to 57.6 per 100000) are displayed in figure 1 [1].  The 
highest incidence is observed in the Scandinavian countries, where Finland has the highest 
one reported while there is a gradual decrease in countries located closer to equator [3].  
However in some areas such as Puerto Rico, Kuwait and Sardinia there is an unexplained 
highly increased incidence [4]. The lowest incidence in the world is observed in China, 
where an  enormous geographic variation in the development risk is observed [5].  A long 
time ago, during the 5th century BC, Hippocrates described diabetes as a ‘rare condition’ 
while later on   Arataeus the Cappadocian described it as ‘not being frequent among men’ 
(http://wwunix.oit.umass.edu/~abhu000/diabetes/index.html). Nowadays the incidence 
of T1DM increases dramatically throughout the world and it is estimated that it may reach 
the status of an epidemic in the 21st century [6].  
A number of 37 studies from 27 countries confirmed the increased incidence for the period 
1960-96 in T1DM with an upward tendency in another 12 countries. The global average 
annual increase was 3.0% per year with a more pronounced relative increase in the 
populations with lower incidence [7]. If these trends continue, the number of new cases 
T1DM in children younger than five years of age may double in some regions between 2005 
and 2020 and prevalent cases in children under 15 years will rise by 70 % [8]. 
The need for rigorous epidemiological studies to monitor the trends of T1DM in children 
less than 15 year of age led to the creation of the World Health Organization ( WHO) -
sponsored Diabetes Mondiale (DIAMOND) [2] Project and the EURODIAB study [9].  
The data from the WHO project for the incidence of T1DM worldwide DIAMOND showed 
a large geographic variability.   This study group was based on 43,013 cases of T1DM from a 
study population of 84 million children aged 14 year old or less during the period 1990-1999 
in 114 populations from 57 countries.  During this time the average annual increase in 
incidence was 2.8% (95% CI 2.4%–3.2%) with a slightly higher rate during 1995 to 1999, 3.4% 
(95% CI 2.7%–4.3%) than during 1990 to 1994, 2.4% (95% CI 1.3%–3.4%).  An increase in the 
incidence of T1DM was observed in the populations studied (4.0% in Asia, 3.2% in Europe, 
and 5.3% in North America) with the exception of Central America and the West Indies, 
where T1D is less prevalent, and where the trend was a decrease of 3.6% [10].  
 It is of interest that several reports have shown an increase in the incidence of T1DM 
worldwide. This tendency implicates an increasing influence of environmental trigger 
factors against a background of genetic susceptibility. The geographic and ethnic variations 
mirror the prevalence of susceptibility genes or that of contributing environmental factors, 
or both.  Nevertheless this increasing incidence rate in such a short period cannot be solely 
attributed   to genetic shifts.  
The EURODIAB ACE study group examined the trends in the incidence of T1DM from 1989 to 
1994. The study was based on 16,362 cases of T1D in 44 European centres and Israel covering a 
population of 28 million children [9]. There were enormous variations in the annual incidence 
rate with 3.2/100,000 person-years in the Former Yugoslav Republic of Macedonia to 
40.2/100,000 person-years in two regions of Finland. During this time the annual increase in 
the incidence rate of T1D was 3.4% (95% CI 2.5%–4.4%) although the rate of increase was noted 
to be higher in some central European countries. The rates of increase were found to be the 
highest in the youngest age group: ages 0 to 4 years (6.3%, 95% CI 1.5%–8.5%), 5 to 9 years 
(3.1%, 95% CI 1.5%–4.8%), and 10 to 14 years (2.4%, 95% CI 1.0%–3.8%).  
www.intechopen.com
 
Altering Trends in the Epidemiology of Type 1 Diabetes Mellitus in Children and Adolescents 
 
325 
 
Fig. 1. Mean Annual Incidence rates for T1DM comparing different countries in the world as 
seen in reference 1.  
Furthermore one of the most notable and recent, in the United States, includes a population-
based study of incidence rates of T1DM from 10 study locations by The SEARCH for 
Diabetes in Youth Study. The Search Group found an overall incidence of T1DM in children 
0–19 of 24.3 per 100,000 person years with the highest rates observed among the 5–9 and 10–
14 age groups with rates of 22.9 and 33.9 per 100,000 respectively [11].  
A recent study from Saudi Arabia over an 18 year period, has shown an average incidence 
of 27.52/100000/year increasing from 18.05/100000/year in the first 9 years of the study 
period to 36.99/100000/year in the next 9 years [12].  Significant increase in incidence of 
T1DM was also observed in Lower Silesia during the period 2000-2005 with an increase 
from 10.43/100000 in 2000 to 13.49/100000 in 2005 [13].  
Additionally in Scotland two studies by Patterson and co-workers [14-15]  have shown an 
increasing incidence from 13, 8/100000/year between 1968 and 1976 and up to 
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21,0/100000/year from 1977 to 1983 for children aged less than 19 year old.  Another study for 
the same population found that the incidence of T1DM had increased from 22,7/100000 in 
1984 to 26,0/100000 in 1993 and this increase of about 2% a year, though small, is statistically 
significant and the effect over 10 years is a large increase [16]. An important increase in 
incidence of T1DM was also observed in Saxony between the five year periods 1999-2003 and 
2004-2008 with estimated rates 15.7/100000 and 19.2/100000 respectively [17]. 
Ιn our study we have ascertained the mean annual  incidence on T1DM in the Greek Cypriot 
population during the period 1990 - 1999   in children younger than 15 years of age. During 
this period the incidence of T1DM  was 10.76 /100000[18].  In order to identify an increase in 
the incidence of T1DM in our country, as occurred in the majority of the populations 
worldwide, we had performed an analysis of the newly diagnosed cases until the end of the 
year 2004.  There was a statistically significant increase in the incidence during the period 
2000-2004 with an estimated mean overall incidence 11.9/100000[19]. We had subsequently 
extended this work by adding the new cases of the five year period 2005 – 2009 in order to 
document this rising trend by comparing the incidence between the two decades (1990-1999 
vs 2000-2009). We have observed a rising trend of the mean incidence from 10.76/100.000 at 
the first decade (1990-1999) of the study up to 14.4/100.000 at the second decade (2000-2009).  
According to Wilcoxon two-sample test this increasing trend of incidence during the 20 
years analysed is  statistically significant (p-value=0.0091). The mean incidence rate for each 
5 year- period in accordance with the population data (population below the age of 15yr) is 
presented in figure 2.  The overall mean incidence of T1DM, in the Greek Cypriot 
population was 12.46/100000 during the twenty-year period 1990-2009.  This raised 
incidence classifies Cyprus among the countries with high incidence of T1DM.   
 
 
Fig. 2. Different annual incidence rates during five year periods. 
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Additionally this rising incidence was more pronounced among children who manifested 
the disease before the age of 5yr. Table 1 shows the percentage of newly diagnosed T1DM 
cases expressed as age group in accordance with the international standards.    
 
Period at 
Diagnosis 
Age Group (years) 
0-4 5-9 10-14 
n % n % n % 
1990-1999 31 19.0 (13.0-25.0) 66 40.5 (33.0-48.0)** 66 40.5 (33.0-48.0)** 
2000-2009 55 26.4 (20.4-32.4) 77 37.0 (30.4-43.6)* 76 36.5 (30.0-43.0)* 
1990-2009 86 23.2 (18.9-27.5) 143 38.5 (33.5-43.5)** 142 38.3 (33.4-43.2)** 
Table 1. Age of diagnosis in total and in the three age groups.  Binomial test performed to 
compare proportions compared to “0-4 year” age group: * p<0.01, **p<0.001 
3. Age of onset 
T1DM formerly called as juvenile diabetes it is one of the most common chronic disease of 
youth as 80% of individuals with T1DM are younger than 20 year of age [20-21].  The age of 
manifestation of childhood onset T1DM has a bimodal allotment with one peak at 4 to 6 
years of age and a second in early puberty (10 to 14 years of age) [22-23]. Recent studies 
report a higher rate of increase among children younger than 5 years than in children 
between 5 and 15 years of age [24-25]. This may be related to an earlier onset of clinical 
manifestation or to a true increase in the causative factors of the disease. 
Although the clinical appearance occurs at all ages [21] one fourth of individuals with 
T1DM are diagnosed as adults [26].  Up to 10% of adults primarily supposed to have type 2 
diabetes are found to have antibodies associated with T1D [27] and beta cell destruction in 
adults seems to take place at a much slower rate than in young T1D cases, often delaying the 
need for insulin therapy after diagnosis. 
4. Gender differences 
Although most autoimmune diseases are more common in females, there appears to be no 
gender difference in the overall incidence of childhood T1DM  [11]. 
However, a gender influence on the age of onset has been reported, in select populations. 
Some data reported from Europe suggest a female predominance in lower risk populations, 
and slight male excess in the high risk groups [3].  Furthermore many reports showed that 
older male adults of European origin (≥15 to 40 years of age) are more likely to develop 
T1DM than females of similar age and geographic location with an approximate 3:2 male to 
female ratio [28-30]. The same 3:2 male to female ratio also was reported in children younger 
than 6 years of age in an observational study from Boston [31]. Based on our data it seems 
that more males develop T1DM at younger age, whereas female predominate during the 
peripubertal period as shown in figure 3.  
5. Seasonal variation at onset and birth 
The first report of seasonal variation in the manifestation of T1DM was presented by 
Franklin Adams in 1926[32] although a consistent picture on the real seasonality of the 
disease has not been established. The increased incidence of T1DM diagnosis during  
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Fig. 3. Ratio of males and females in relation to year of diagnosis (at 2-yr intervals). 
Autumn and Winter months could support the hypothesis that infections may act as 
participating factors in the clinical onset of the disease, possibly accelerating an autoimmune 
process that may have been initiated months or years before [33].  Based on the average 
temperature record in our island, the newly diagnosed cased were grouped according to the 
month of diagnosis as follow: November, December, January, and February were defined as 
cold months, October, March, April and May as neutral months and, June, July , August and  
September, as warm months. More children were significantly diagnosed with T1DM 
during the cold months compared to those who manifested the disease during the warm 
months (p<0.001), whereas no difference was observed in the incidence between neutral and 
cold months ((p>0.05) throughout the study period (1990-2009) as depicted in Table 2.  A 
recent study on seasonal variation in DM in 53 countries has suggested that seasonality in 
the diagnosis of T1DM occurs and that the pattern of seasonality appears to be related to the 
geographical position, at least as far as the northern/southern hemisphere dichotomy is 
concerned [34].  
 
Period at 
Diagnosis 
Month at Diagnosis 
Cold Months Neutral Months Warm Months 
n % n % n % 
1990-1999 64 38.6 (31.2-46.0) 61 36.7 (29.4-44.0)* 41 
24.7 (18.1-
31.3)**** 
2000-2009 82 39.4 (32.8-46.0) 67 32.2 (25.9-38.5)** 59 28.4 (22.3-34.5)*** 
1990-2009 146 39.0 (34.1-43.9) 128 34.2 (29.4-39.0)* 100 
26.7 (22.2-
31.2)**** 
Table 2. Percentage of children diagnosed with T1DM at cold months, neutral months and 
warm months.   Binomial test performed to compare proportions compared to “Cold 
Months” group: * NS (p>0.05), ** p<0.05, *** p<0.01, ****p<0.001 
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A seasonal variation of birth has been also observed in children who developed T1DM later 
in life in many countries, which suggests that environmental factors during pregnancy, in 
the neonatal period or very early in life play a role in its development.  Several studies from 
Europe [35-37] and Israel [38] showed higher rates of T1DM among youth born in spring 
and lower rates among youth born in winter. Although McKinney maintained that there is 
no relationship between T1DM diagnosis and date of birth[39].  It has been suggested that 
seasonability pattern may be explained by reduced vitamin D production [40] during the 
critical intrauterine and neonatal periods of life. 
6. Genotype 
The genetics of T1DM cannot be classified according to a specific model of inheritance.  
Susceptibility to autoimmune T1DM is determined by multiple genes with HLA genes 
having the strongest known association.   HLA antigens are present on the surface of the 
leucocytes and participate in some immune reactions.  The genes coding for these antigens 
are located on chromosome 6.  The class II sub region of HLA consists of the DR, DQ, and 
DP loci.  These class II molecules are involved to the immune destruction of the pancreatic 
beta cells because they participate in the presentation of the antigen to the helper T cell, 
which initiates the immune reaction. 
Inheritance of HLA-DR3 and HLA-DR4 appears to confer a 2 to 3 fold increased risk for the 
development of T1DM.  When both HLA-DR3 and HLA-DR4 are inherited the relative risk 
for the development of T1DM is increased by 7-10 folds. It is estimated that 48 percent of the 
familial aggregation can now be ascribed to known loci, and the Major Histocompatibility 
Complex (MHC) contributes 41 percent [41]. As an example, siblings with the highest risk 
HLA DR and DQ alleles, who inherit both HLA regions identical by descent to their diabetic 
sibling, may have a risk of developing anti-islet autoimmunity as high as 80 percent and a 
similar long-term risk of diabetes[42].  Moreover HLA DR2 and HLA DR5 are both 
protective in most studies.  Furthermore, stronger associations of DM1 have been reported 
with other MHC loci: HLA-DQA1 and DQB1 antigens[43].  
In our effort to detect the genetic susceptibility of Greek Cypriot population to DM1, we 
studied 101 DM1 patients with age of onset less than 15 years through HLA serological 
typing for the DR and DQ1 alleles and compared them to 209 healthy controls.  Our findings 
support the strong association of HLA-DR4 and DR3 with DM1.  The most frequent allelic 
combination was that of HLA-DR3/DR4 (27%) followed by that of DR2/DR4 (21.6%).  The 
percentage of HLA antigens in patients with DM1 and controls are shown in figure 4. The 
protective role of HLA-DR5 was shown, whereas the presence of HLA-DR2 is neutral, in 
contrast with most findings among Caucasian population where DR2 is protective.  In 
addition, high resolution testing of the DR4 and DR3 alleles revealed the predominant 
presence of the DRB1*0403 (0% vs 36%), similar frequency of the DRB1*0402 in both groups 
(19% vs 14%) and that the DRB1*301 was the only DR3 allele detected.  The DQB1 alleles 
present in our T1DM patients as  shown in figure 5   were nearly exclusively DQB1*0201 and  
DQB1*0302  [44]. The relative risk of developing T1DM in children carrying the DQB1*0201 
and the DQB1*0302 alleles is 5.05 and 2.56 respectively whereas the protective role of 
DQB1*0301 is documented.    
Furthermore, although most T1D cases occur in individuals without a family history of the 
disease, T1D is strongly influenced by genetic factors. The lifelong risk of T1DM is markedly  
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Fig. 4. HLA antigens in DM1 patients and controls. 
 
 
Fig. 5. HLA DQ B1 alleles in DM1 patients and controls. 
increased in close relatives of a patient with T1DM, averaging about 6 percent in offspring, 5 
percent in siblings and 50 percent in identical twins (versus 0.4 percent in subjects with no 
family history) [45-46]. T1DM is 2-3 times more common in the offspring of diabetic men 
(3.6-8.5%) compared with diabetic woman (1.3-3.6%) [1]. A monozygotic twin of a patient 
with type 1 diabetes has a higher risk of diabetes than a dizygotic twin, and the risk in a 
dizygotic twin sibling is similar to that in non-twin siblings [46].  
Additionally age at onset is inversely related to the proportion of HLA haplotypes, and 
young children with T1DM show the greatest HLA-associated genetic risk. Siblings of 
children with onset of T1D before the age of 5 years have a 3- to 5-fold greater cumulative 
risk of diabetes by age 20 years compared with siblings of children diagnosed between 5 and 
15 years of age [47].  Several reports suggest a higher proportion of lower risk haplotypes 
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and in association with the decreased age at onset of T1DM are consisted with a major 
environmental effect on the development of the disease [48-51].  
T1DM is associated with other autoimmune diseases such as thyroiditis, celiac disease, 
autoimmune gastritis and Addison disease [52]. The coexistence of these autoimmune 
diseases is associated to genes within the MHC  complex [52]. 
7. Other risk factors 
The variations in the incidence of T1DM in different countries its rising in rich and 
developed countries have raised questions about changes in environmental risk factors that 
may either initiate or accelerate the autoimmune process leading to pancreatic β-pancreatic 
cell destruction. 
Reports have linked several environmental factors to an increased risk of T1DM; however, 
none of these have associations have verified and many have been contradicted by other 
studies.  They include: viral infections in infancy and early childhood, maternal viral 
infection during pregnancy [53], early exposure to cow’s milk and other nutritional factors 
[54], chemical contamination of food and water [55], high birth weight and an increase in 
body mass index [56].  
Viruses that have been associated with T1DM as environmental triggers include enteroviruses, 
mumps, rubella, cytomegalovirus, rotavirus and Epstein-Barr virus. The one proven 
environmental virus trigger T1DM is congenital rubella [57]. Many epidemiological studies 
have been supported the involvement of enteroviruses, especially the Coxsackie B viruses in 
the aetiology which appears to trigger β cell autoimmunity [58-59]. Furthermore it has been 
hypothesized that excessive weight gain and increase in insulin resistance in early childhood is 
trigger event which initiates the autoimmunity leading to β cell destruction and this 
Accelerator Hypothesis has been supported by several epidemiological studies [56, 60-61].  
A number of dietary factors may influence the development of T1DM in infants at high risk 
for T1DM.  Early introduction to the infant diet of cattle proteins, lack or short lasting breast 
feeding might be reasons for development of immunological reaction leading to the 
destruction of pancreatic beta cells [62].   In two large prospective cohort studies of 
newborns at high risk for T1DM diabetes (either a first degree relative [63-64] or a high risk 
HLA genotype) [63], first exposure to cereal before age three months [63-64]  or after seven 
months [63] was associated with an increased risk of developing autoantibodies (IA) 
compared to infants whose first exposure was between ages four to six months. The 
increased risk was associated with gluten-containing cereals in one study [64], but with 
either gluten or rice-containing cereals in the other [63]. 
On the other hand Vitamin D and omega-3 fatty acids may have a protective role.  A case 
control study in seven European countries suggested that supplementation with vitamin D 
in early infancy can protect against development of T1DM [65].  A similar protective effect 
was found in a birth-cohort study of over 10,000 children [66].  Moreover preliminary 
studies in animals sustain a protective role of omega-3 fatty acids in the inflammatory 
reaction associated with autoimmune islet cell damage [67-68]. 
In conclusion there is no doubt that the incidence of T1DM is increasing dramatically. Data 
from large epidemiological studies worldwide indicate that the incidence of T1DM has been 
increasing by 2% to 5% worldwide [69] and this is of concern because of its health and 
resource implications. This rising incidence of T1DM in young children has been confirmed 
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to a genetically susceptible subgroup of the population (48). The heightened proportion of 
lower risk hapltotypes and decreased median age at onset of T1DM within the subgroup are 
consistent with a major environmental effect on Diabetes development (50).  
8. Epilogue 
It is a an actuality  that significant advances have been made in the clinical care of T1DM, 
which ultimately improved the clinical outcomes. However much more need to be done 
to find a cure for T1DM. In the absence of an ideal therapy Diabetes will always be a 
hurdle in the quality of life of these children. Moreover the increasing incidence is of 
concern because of its health and resource implications.  There is a great research 
potential and more studies are required to identify the environmental factors that trigger 
the autoimmune destruction of the pancreatic beta cell particularly in some populations 
and individuals, who are not genetically predisposed to develop T1DM.  These 
environmental triggers if ever identified could potentially be targeted for new preventive 
strategies and optimal intervention.   
9. References 
[1] Craig, M.E., A. Hattersley, and K.C. Donaghue, Definition, epidemiology and classification of 
diabetes in children and adolescents. Pediatr Diabetes, 2009. 10 Suppl 12: p. 3-12. 
[2] Karvonen, M., et al., Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale 
(DiaMond) Project Group. Diabetes Care, 2000. 23(10): p. 1516-26. 
[3] Green, A., E.A. Gale, and C.C. Patterson, Incidence of childhood-onset insulin-dependent 
diabetes mellitus: the EURODIAB ACE Study. Lancet, 1992. 339(8798): p. 905-9. 
[4] Eisenbarth, G.S., Immunology of type 1 diabetes. 2nd ed. 2004: Plenum Publishers. 
[5] Yang, Z., et al., Childhood diabetes in China. Enormous variation by place and ethnic group. 
Diabetes Care, 1998. 21(4): p. 525-9. 
[6] Silink, M., Childhood diabetes: a global perspective. Horm Res, 2002. 57 Suppl 1: p. 1-5. 
[7] Onkamo, P., et al., Worldwide increase in incidence of Type I diabetes--the analysis of the data 
on published incidence trends. Diabetologia, 1999. 42(12): p. 1395-403. 
[8] Patterson, C.C., et al., Incidence trends for childhood type 1 diabetes in Europe during 1989-
2003 and predicted new cases 2005-20: a multicentre prospective registration study. 
Lancet, 2009. 373(9680): p. 2027-33. 
[9] Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study 
Group. Lancet, 2000. 355(9207): p. 873-6. 
[10] Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med, 2006. 
23(8): p. 857-66. 
[11] Dabelea, D., et al., Incidence of diabetes in youth in the United States. JAMA, 2007. 297(24): 
p. 2716-24. 
[12] Al-Mendalawi, M.D., et al., Incidence trends of childhood type 1 diabetes in eastern Saudi 
Arabia. Saudi Med J, 2010. 31(9): p. 1074-5; author reply 1074-5. 
[13] Zubkiewicz-Kucharska, A. and A. Noczynska, [Epidemiology of type 1 diabetes in 
Lower Silesia in the years 2000-2005]. Pediatr Endocrinol Diabetes Metab, 2010. 
16(1): p. 45-9. 
www.intechopen.com
 
Altering Trends in the Epidemiology of Type 1 Diabetes Mellitus in Children and Adolescents 
 
333 
[14] Patterson, C.C., et al., Increasing prevalence of diabetes mellitus in children. Br Med J (Clin 
Res Ed), 1983. 287(6386): p. 213-4. 
[15] Patterson, C.C., et al., Geographical variation in the incidence of diabetes mellitus in Scottish 
children during the period 1977-1983. Diabet Med, 1988. 5(2): p. 160-5. 
[16] Rangasami, J.J., et al., Rising incidence of type 1 diabetes in Scottish children, 1984-93. The 
Scottish Study Group for the Care of Young Diabetics. Arch Dis Child, 1997. 77(3): p. 
210-3. 
[17] Galler, A., et al., Incidence of childhood diabetes in children aged less than 15 years and 
its clinical and metabolic characteristics at the time of diagnosis: data from the 
Childhood Diabetes Registry of Saxony, Germany. Horm Res Paediatr, 2010. 74(4): 
p. 285-91. 
[18] Skordis, N., et al., The incidence of type 1 diabetes mellitus in Greek-Cypriot children and 
adolescents in 1990-2000. Pediatr Diabetes, 2002. 3(4): p. 200-4. 
[19] Toumba, M., et al., Rising incidence of type 1 diabetes mellitus in children and adolescents in 
Cyprus in 2000-2004. Pediatr Diabetes, 2007. 8(6): p. 374-6. 
[20] Liese, A.D., et al., The burden of diabetes mellitus among US youth: prevalence estimates from 
the SEARCH for Diabetes in Youth Study. Pediatrics, 2006. 118(4): p. 1510-8. 
[21] Thunander, M., et al., Incidence of type 1 and type 2 diabetes in adults and children in 
Kronoberg, Sweden. Diabetes Res Clin Pract, 2008. 82(2): p. 247-55. 
[22] Felner, E.I., et al., Genetic interaction among three genomic regions creates distinct 
contributions to early- and late-onset type 1 diabetes mellitus. Pediatr Diabetes, 2005. 
6(4): p. 213-20. 
[23] Elamin, A., et al., Epidemiology of childhood type I diabetes in Sudan, 1987-1990. Diabetes 
Care, 1992. 15(11): p. 1556-9. 
[24] Karvonen, M., J. Pitkaniemi, and J. Tuomilehto, The onset age of type 1 diabetes in Finnish 
children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes 
Care, 1999. 22(7): p. 1066-70. 
[25] Schoenle, E.J., et al., Epidemiology of type I diabetes mellitus in Switzerland: steep rise in 
incidence in under 5 year old children in the past decade. Diabetologia, 2001. 44(3): p. 
286-9. 
[26] Haller, M.J., M.A. Atkinson, and D. Schatz, Type 1 diabetes mellitus: etiology, presentation, 
and management. Pediatr Clin North Am, 2005. 52(6): p. 1553-78. 
[27] Turner, R., et al., UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid 
decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective 
Diabetes Study Group. Lancet, 1997. 350(9087): p. 1288-93. 
[28] Gale, E.A. and K.M. Gillespie, Diabetes and gender. Diabetologia, 2001. 44(1): p. 3-15. 
[29] Weets, I., et al., The incidence of type 1 diabetes in the age group 0-39 years has not increased 
in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation. 
Diabetes Care, 2002. 25(5): p. 840-6. 
[30] Pundziute-Lycka, A., et al., The incidence of Type I diabetes has not increased but shifted to a 
younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia, 
2002. 45(6): p. 783-91. 
[31] Quinn, M., et al., Characteristics at diagnosis of type 1 diabetes in children younger than 6 
years. J Pediatr, 2006. 148(3): p. 366-71. 
www.intechopen.com
 
Type 1 Diabetes – Complications, Pathogenesis, and Alternative Treatments 
 
334 
[32] Adams, F., The seasonal variation in the onset of acute diabetes. The age and sex factors in 
1000 diabetic patients. Arch Intern Med, 1926. 37: p.:861-864. 
[33] Jun, H.S. and J.W. Yoon, A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev, 
2003. 19(1): p. 8-31. 
[34] Moltchanova, E.V., et al., Seasonal variation of diagnosis of Type 1 diabetes mellitus in 
children worldwide. Diabet Med, 2009. 26(7): p. 673-8. 
[35] Vaiserman, A.M., et al., Seasonality of birth in children and young adults (0-29 years) with 
type 1 diabetes in Ukraine. Diabetologia, 2007. 50(1): p. 32-5. 
[36] Jongbloet, P.H., et al., Seasonality of birth in patients with childhood diabetes in The 
Netherlands. Diabetes Care, 1998. 21(1): p. 190-1. 
[37] Samuelsson, U., C. Johansson, and J. Ludvigsson, Month of birth and risk of 
developing insulin dependent diabetes in south east Sweden. Arch Dis Child, 1999. 
81(2): p. 143-6. 
[38] Laron, Z., et al., Month of birth and subsequent development of type I diabetes (IDDM). J 
Pediatr Endocrinol Metab, 1999. 12(3): p. 397-402. 
[39] McKinney, P.A., Seasonality of birth in patients with childhood Type I diabetes in 19 
European regions. Diabetologia, 2001. 44 Suppl 3: p. B67-74. 
[40] Mohr, S.B., et al., The association between ultraviolet B irradiance, vitamin D status and 
incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia, 2008. 51(8): p. 
1391-8. 
[41] Todd, J.A., et al., Robust associations of four new chromosome regions from genome-wide 
analyses of type 1 diabetes. Nat Genet, 2007. 39(7): p. 857-64. 
[42] Aly, T.A., et al., Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A, 2006. 
103(38): p. 14074-9. 
[43] Thorsby, E. and K.S. Ronningen, Particular HLA-DQ molecules play a dominant role in 
determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. 
Diabetologia, 1993. 36(5): p. 371-7. 
[44] Stylianou, C.H., Apsiotou, N., Stavrou, S., Demetriades, M., Kyriakou, A., Costeas, P., 
Skordis, N., Detection of HLA-DR and DQB1 alleles, which predispose to diabetes 
mellitus type 1 in the Greek Cypriot population. Hormone Research, 2003. 60( (Suppl 
I)): p. 136. 
[45] Atkinson, M.A. and N.K. Maclaren, The pathogenesis of insulin-dependent diabetes mellitus. 
N Engl J Med, 1994. 331(21): p. 1428-36. 
[46] Redondo, M.J., et al., Genetic determination of islet cell autoimmunity in monozygotic twin, 
dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin 
study. BMJ, 1999. 318(7185): p. 698-702. 
[47] Gillespie, K.M., E.A. Gale, and P.J. Bingley, High familial risk and genetic susceptibility in 
early onset childhood diabetes. Diabetes, 2002. 51(1): p. 210-4. 
[48] Gillespie, K.M., et al., The rising incidence of childhood type 1 diabetes and reduced 
contribution of high-risk HLA haplotypes. Lancet, 2004. 364(9446): p. 1699-700. 
[49] Hermann, R., et al., Temporal changes in the frequencies of HLA genotypes in patients with 
Type 1 diabetes--indication of an increased environmental pressure? Diabetologia, 2003. 
46(3): p. 420-5. 
www.intechopen.com
 
Altering Trends in the Epidemiology of Type 1 Diabetes Mellitus in Children and Adolescents 
 
335 
[50] Gale, E.A., The rise of childhood type 1 diabetes in the 20th century. Diabetes, 2002. 51(12): 
p. 3353-61. 
[51] Vehik, K., et al., Trends in high-risk HLA susceptibility genes among Colorado youth with 
type 1 diabetes. Diabetes Care, 2008. 31(7): p. 1392-6. 
[52] Tsirogianni, A., E. Pipi, and K. Soufleros, Specificity of islet cell autoantibodies and 
coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. 
Autoimmun Rev, 2009. 8(8): p. 687-91. 
[53] Dahlquist, G.G., et al., Maternal enteroviral infection during pregnancy as a risk factor for 
childhood IDDM. A population-based case-control study. Diabetes, 1995. 44(4): p. 408-
13. 
[54] Akerblom, H.K., et al., Dietary manipulation of beta cell autoimmunity in infants at 
increased risk of type 1 diabetes: a pilot study. Diabetologia, 2005. 48(5): p. 829-37. 
[55] Longnecker, M.P. and J.L. Daniels, Environmental contaminants as etiologic factors for 
diabetes. Environ Health Perspect, 2001. 109 Suppl 6: p. 871-6. 
[56] Hypponen, E., et al., Obesity, increased linear growth, and risk of type 1 diabetes in children. 
Diabetes Care, 2000. 23(12): p. 1755-60. 
[57] McIntosh, E.D. and M.A. Menser, A fifty-year follow-up of congenital rubella. Lancet, 1992. 
340(8816): p. 414-5. 
[58] Rewers, M. and P. Zimmet, The rising tide of childhood type 1 diabetes--what is the elusive 
environmental trigger? Lancet, 2004. 364(9446): p. 1645-7. 
[59] Salminen, K., et al., Enterovirus infections are associated with the induction of beta-cell 
autoimmunity in a prospective birth cohort study. J Med Virol, 2003. 69(1): p. 91-8. 
[60] Betts, P., et al., Increasing body weight predicts the earlier onset of insulin-dependant 
diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med, 2005. 
22(2): p. 144-51. 
[61] Evertsen, J., R. Alemzadeh, and X. Wang, Increasing incidence of pediatric type 1 diabetes 
mellitus in Southeastern Wisconsin: relationship with body weight at diagnosis. PLoS 
One, 2009. 4(9): p. e6873. 
[62] Virtanen, S.M. and M. Knip, Nutritional risk predictors of beta cell autoimmunity and type 1 
diabetes at a young age. Am J Clin Nutr, 2003. 78(6): p. 1053-67. 
[63] Norris, J.M., et al., Timing of initial cereal exposure in infancy and risk of islet autoimmunity. 
JAMA, 2003. 290(13): p. 1713-20. 
[64] Ziegler, A.G., et al., Early infant feeding and risk of developing type 1 diabetes-associated 
autoantibodies. JAMA, 2003. 290(13): p. 1721-8. 
[65] Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes 
mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia, 1999. 42(1): p. 51-4. 
[66] Hypponen, E., et al., Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. 
Lancet, 2001. 358(9292): p. 1500-3. 
[67] Kleemann, R., et al., Impact of dietary fat on Th1/Th2 cytokine gene expression in the 
pancreas and gut of diabetes-prone BB rats. J Autoimmun, 1998. 11(1): p. 97-103. 
[68] Krishna Mohan, I. and U.N. Das, Prevention of chemically induced diabetes mellitus in 
experimental animals by polyunsaturated fatty acids. Nutrition, 2001. 17(2): p. 126-
51. 
www.intechopen.com
 
Type 1 Diabetes – Complications, Pathogenesis, and Alternative Treatments 
 
336 
[69] Maahs, D.M., et al., Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am, 
2010. 39(3): p. 481-97. 
www.intechopen.com
Type 1 Diabetes - Complications, Pathogenesis, and Alternative
Treatments
Edited by Prof. Chih-Pin Liu
ISBN 978-953-307-756-7
Hard cover, 470 pages
Publisher InTech
Published online 21, November, 2011
Published in print edition November, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
This book is intended as an overview of recent progress in type 1 diabetes research worldwide, with a focus on
different research areas relevant to this disease. These include: diabetes mellitus and complications,
psychological aspects of diabetes, perspectives of diabetes pathogenesis, identification and monitoring of
diabetes mellitus, and alternative treatments for diabetes. In preparing this book, leading investigators from
several countries in these five different categories were invited to contribute a chapter to this book. We have
striven for a coherent presentation of concepts based on experiments and observation from the authors own
research and from existing published reports. Therefore, the materials presented in this book are expected to
be up to date in each research area. While there is no doubt that this book may have omitted some important
findings in diabetes field, we hope the information included in this book will be useful for both basic science
and clinical investigators. We also hope that diabetes patients and their family will benefit from reading the
chapters in this book.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Elisavet Efstathiou and Nicos Skordis (2011). Altering Trends in the Epidemiology of Type 1 Diabetes Mellitus
in Children and Adolescents, Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments,
Prof. Chih-Pin Liu (Ed.), ISBN: 978-953-307-756-7, InTech, Available from:
http://www.intechopen.com/books/type-1-diabetes-complications-pathogenesis-and-alternative-
treatments/altering-trends-in-the-epidemiology-of-type-1-diabetes-mellitus-in-children-and-adolescents
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
